Published on in Vol 12 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/49252, first published .
An eHealth App (CAPABLE) Providing Symptom Monitoring, Well-Being Interventions, and Educational Material for Patients With Melanoma Treated With Immune Checkpoint Inhibitors: Protocol for an Exploratory Intervention Trial

An eHealth App (CAPABLE) Providing Symptom Monitoring, Well-Being Interventions, and Educational Material for Patients With Melanoma Treated With Immune Checkpoint Inhibitors: Protocol for an Exploratory Intervention Trial

An eHealth App (CAPABLE) Providing Symptom Monitoring, Well-Being Interventions, and Educational Material for Patients With Melanoma Treated With Immune Checkpoint Inhibitors: Protocol for an Exploratory Intervention Trial

Journals

  1. Miulescu A, Kozma A, Cucu D. Digital Medicine: from SPA to Medical Recovery. Balneo and PRM Research Journal 2023;14(Vol.14, no. 4):635 View
  2. Glaser S, Fraterman I, van Brummelen N, Tibollo V, Del Campo L, Mallo H, Wilgenhof S, Wilk S, Gisko V, Khadakou V, Cornet R, Ottaviano M, Medlock S. Usability and Usefulness of a Symptom Management Coaching System for Cancer Patients treated with Immune Checkpoint Inhibitors: a Comparative Mixed-Methods Study (Preprint). JMIR Formative Research 2024 View
  3. Finkelstein J, Smiley A, Echeverria C, Mooney K. AI-Driven Prediction of Symptom Trajectories in Cancer Care: A Deep Learning Approach for Chemotherapy Management. Bioengineering 2024;11(11):1172 View
  4. Fraterman I, Sacchi L, Mallo H, Tibollo V, Glaser S, Medlock S, Cornet R, Gabetta M, Hisko V, Khodakou V, Barkan E, Del Campo L, Glasspool D, Kogan A, Lanzola G, Leizer R, Ottaviano M, Peleg M, Śniatała K, Lisowska A, Wilk S, Parimbelli E, Quaglini S, Rizzo M, Locati L, Boekhout A, van de Poll-Franse L, Wilgenhof S. Exploring the impact of the multimodal CAPABLE eHealth intervention on health-related quality of life in melanoma patients undergoing immune-checkpoint inhibition: A prospective pilot study (Preprint). JMIR Cancer 2024 View